Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

23andMe, Wojcicki

Entrepreneur on MSN · 2h
23andMe's Former CEO Anne Wojcicki Just Regained Control of the Company She Cofounded. Here's How.
TTAM replaces biotech company Regeneron as 23andMe's buyer. Last month, Regeneron won the bidding during the bankruptcy auction to purchase 23andMe for $256 million. Wojcicki reop
Los Angeles Times on MSN · 2d
Anne Wojcicki's nonprofit wins bid for genetic testing company 23andMe
The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne Wojcicki.
Fierce Biotech · 2h
Former CEO Anne Wojcicki prevails in 23andMe auction, with final $305M bid
Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, and its trove of genetic data.  | Her $305 million offer topped the previous frontrunner,
26m
23andMe's Founder Wins Bid For Bankrupt DNA Testing Firm
June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...
3h
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
57m
How to delete your 23andMe data
To delete your data from 23andMe, you need to log in to your account and then follow these steps: Navigate to the Settings ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy